BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33385070)

  • 1. Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia.
    Mackenzie P; Vajdic C; Delaney G; Gabriel G; Agar M; Comans T; Barton M
    Tech Innov Patient Support Radiat Oncol; 2020 Dec; 16():17-23. PubMed ID: 33385070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers.
    Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M
    Radiother Oncol; 2023 Nov; 188():109862. PubMed ID: 37619661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an age- and comorbidity adjusted- optimal radiotherapy utilisation rate for women with breast cancer.
    Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M
    J Geriatr Oncol; 2022 Jul; 13(6):844-849. PubMed ID: 35514015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review.
    Mackenzie P; Vajdic C; Delaney G; Comans T; Morris L; Agar M; Gabriel G; Barton M
    J Geriatr Oncol; 2023 Apr; 14(3):101387. PubMed ID: 36272958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of radiotherapy underutilisation measured by survival shortfall, years of potential life lost and disability-adjusted life years lost in New South Wales, Australia.
    Batumalai V; Shafiq J; Gabriel G; Hanna TP; Delaney GP; Barton M
    Radiother Oncol; 2018 Nov; 129(2):191-195. PubMed ID: 29983259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of travel distance on radiotherapy utilization in NSW and ACT.
    Gabriel G; Barton M; Delaney GP
    Radiother Oncol; 2015 Nov; 117(2):386-9. PubMed ID: 26243679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decade of investment in radiotherapy in New South Wales: why does the gap between optimal and actual persist?
    Barton MB; Delaney GP
    J Med Imaging Radiat Oncol; 2011 Aug; 55(4):433-41. PubMed ID: 21843180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes to radiotherapy utilisation in Western NSW after the opening of a local service.
    Butler SM
    J Med Radiat Sci; 2017 Dec; 64(4):251-258. PubMed ID: 28160454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy underutilisation and its impact on local control and survival in New South Wales, Australia.
    Merie R; Gabriel G; Shafiq J; Vinod S; Barton M; Delaney GP
    Radiother Oncol; 2019 Dec; 141():41-47. PubMed ID: 31606225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated With Radiotherapy Utilisation In New South Wales, Australia: Results From The 45 and Up Study.
    Yap ML; O'Connell DL; Goldsbury D; Weber M; Barton M
    Clin Oncol (R Coll Radiol); 2020 May; 32(5):282-291. PubMed ID: 32007353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of an optimal utilisation rate for palliative radiotherapy in newly diagnosed cancer patients.
    Jacob S; Wong K; Delaney GP; Adams P; Barton MB
    Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):56-64. PubMed ID: 19969443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provincial variations in radiotherapy utilization as a measure of access: A pan-Canadian study.
    Chan J; Brown E; Dennis K; Milosevic M; Brundage M
    Radiother Oncol; 2022 Feb; 167():122-126. PubMed ID: 34942281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actual Versus Optimal Radiotherapy Utilisation for Metastatic Cancer Patients in the 45 and Up Study Cohort, New South Wales.
    Yap ML; O'Connell DL; Goldsbury DE; Weber MF; Barton MB
    Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):650-660. PubMed ID: 33750600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy utilization in developing countries: An IAEA study.
    Rosenblatt E; Fidarova E; Zubizarreta EH; Barton MB; Jones GW; Mackillop WJ; Cordero L; Yarney J; Lim G; Gan JV; Cernea V; Stojanovic-Rundic S; Strojan P; Kochbati L; Quarneti A
    Radiother Oncol; 2018 Sep; 128(3):400-405. PubMed ID: 29859755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer treatment and survival differences in women in remote and socioeconomically disadvantaged areas, as demonstrated by linked data from New South Wales (NSW), Australia.
    Buckley E; Elder E; McGill S; Kargar ZS; Li M; Roder D; Currow D
    Breast Cancer Res Treat; 2021 Jul; 188(2):547-560. PubMed ID: 33748922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical and radiotherapy patterns of care in the management of breast cancer in NSW and ACT Australia.
    Merie R; Shafiq J; Soon PS; Delaney GP
    J Med Imaging Radiat Oncol; 2022 Apr; 66(3):442-454. PubMed ID: 34851031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing criterion-based benchmarking for the appropriate use of radiotherapy.
    Barton MB; Gabriel GS; Delaney GP
    Radiother Oncol; 2018 Sep; 128(3):406-410. PubMed ID: 29880221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of care and survival of older patients with malignant pleural mesothelioma.
    Linton A; Blinman P; Kao S; van Zandwijk N
    J Geriatr Oncol; 2019 Jul; 10(4):573-576. PubMed ID: 30917938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of four methods for estimating actual radiotherapy utilisation using the 45 and Up Study cohort in New South Wales, Australia.
    Yap ML; O'Connell DL; Goldsbury D; Weber M; Barton M
    Radiother Oncol; 2019 Feb; 131():14-20. PubMed ID: 30773181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy utilization in New South Wales from 1996 to 1998.
    Barton M
    Australas Radiol; 2000 Aug; 44(3):308-14. PubMed ID: 10974725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.